• Something wrong with this record ?

Procalcitonin Dynamics After Long-Term Ventricular Assist Device Implantation

J. Kettner, M. Holek, J. Franekova, A. Jabor, M. Pindak, H. Riha, J. Kautzner, J. Pirk,

. 2017 ; 26 (6) : 599-603. [pub] 20161116

Language English Country Australia

Document type Journal Article, Observational Study

BACKGROUND: Infectious complications (IC) are one of the main causes of worsening prognosis after long-term ventricular assist device (LVAD) implantation. Procalcitonin (PCT) is widely used for diagnosis of a bacterial infection. The objective of this study was to assess PCT dynamics after LVAD surgery and their relationship to the infectious complications. METHODS: A total of 25 consecutive patients indicated for LVAD implantation as a bridge to heart transplant were included. Procalcitonin levels were prospectively assessed before surgery and during the postoperative period (day 1, 2, 14 and 30). Values were compared according to the presence of IC. RESULTS: Procalcitonin levels were low before surgery, raised significantly within 1st and 2nd day after operation and decreased in the 14th and 30th days back to the baseline. There was no significant difference in PCT values between patients with or without IC as well as with or without right ventricle assist device (RVAD). Acute renal failure (ARF) increased PCT significantly only 14 days after LVAD implantation. In patients with ARF and/or RVAD we observed significantly higher PCT values in the 2nd, 14thand 30thday after operation. In subjects with IC and/or ARF and/or RVAD we also observed significantly elevated PCT concentrations 2 and 14 days after surgery. CONCLUSIONS: Our data show that the ability of PCT to detect IC in patients after LVAD implantation is limited and its concentrations more likely correlate with postoperative complications in general.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010845
003      
CZ-PrNML
005      
20180417152728.0
007      
ta
008      
180404s2017 at f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.hlc.2016.09.014 $2 doi
035    __
$a (PubMed)28111176
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a at
100    1_
$a Kettner, Jiri $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Procalcitonin Dynamics After Long-Term Ventricular Assist Device Implantation / $c J. Kettner, M. Holek, J. Franekova, A. Jabor, M. Pindak, H. Riha, J. Kautzner, J. Pirk,
520    9_
$a BACKGROUND: Infectious complications (IC) are one of the main causes of worsening prognosis after long-term ventricular assist device (LVAD) implantation. Procalcitonin (PCT) is widely used for diagnosis of a bacterial infection. The objective of this study was to assess PCT dynamics after LVAD surgery and their relationship to the infectious complications. METHODS: A total of 25 consecutive patients indicated for LVAD implantation as a bridge to heart transplant were included. Procalcitonin levels were prospectively assessed before surgery and during the postoperative period (day 1, 2, 14 and 30). Values were compared according to the presence of IC. RESULTS: Procalcitonin levels were low before surgery, raised significantly within 1st and 2nd day after operation and decreased in the 14th and 30th days back to the baseline. There was no significant difference in PCT values between patients with or without IC as well as with or without right ventricle assist device (RVAD). Acute renal failure (ARF) increased PCT significantly only 14 days after LVAD implantation. In patients with ARF and/or RVAD we observed significantly higher PCT values in the 2nd, 14thand 30thday after operation. In subjects with IC and/or ARF and/or RVAD we also observed significantly elevated PCT concentrations 2 and 14 days after surgery. CONCLUSIONS: Our data show that the ability of PCT to detect IC in patients after LVAD implantation is limited and its concentrations more likely correlate with postoperative complications in general.
650    _2
$a dospělí $7 D000328
650    _2
$a bakteriální infekce $x krev $x etiologie $7 D001424
650    _2
$a kalcitonin $x krev $7 D002116
650    _2
$a ženské pohlaví $7 D005260
650    12
$a podpůrné srdeční systémy $7 D006353
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $x krev $7 D011183
650    _2
$a pooperační období $7 D011184
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Holek, Martin $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 3(rd) Faculty of Medicine, Charles University in Prague, 3 Prague, Czech Republic. Electronic address: martin.holek@ikem.cz.
700    1_
$a Franekova, Janka $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 3(rd) Faculty of Medicine, Charles University in Prague, 3 Prague, Czech Republic.
700    1_
$a Jabor, Antonin $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 3(rd) Faculty of Medicine, Charles University in Prague, 3 Prague, Czech Republic.
700    1_
$a Pindak, Marian $u Department of Anesthesiology and Intensive Care Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Riha, Hynek $u Department of Anesthesiology and Intensive Care Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Pirk, Jan $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
773    0_
$w MED00007206 $t Heart, lung & circulation $x 1444-2892 $g Roč. 26, č. 6 (2017), s. 599-603
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28111176 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180417152826 $b ABA008
999    __
$a ok $b bmc $g 1288330 $s 1007657
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 26 $c 6 $d 599-603 $e 20161116 $i 1444-2892 $m Heart, lung & circulation $n Heart Lung Circ $x MED00007206
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...